Bioacoustics Sensor
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Cancer Tissue Diagnostics Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Tissue Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Immunohistochemistry (IHC) Test
1.2.3 In Situ Hybridisation Test
1.3 Market by Application
1.3.1 Global Cancer Tissue Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Tissue Diagnostics Market Perspective (2017-2028)
2.2 Cancer Tissue Diagnostics Growth Trends by Region
2.2.1 Cancer Tissue Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Tissue Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Cancer Tissue Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Cancer Tissue Diagnostics Market Dynamics
2.3.1 Cancer Tissue Diagnostics Industry Trends
2.3.2 Cancer Tissue Diagnostics Market Drivers
2.3.3 Cancer Tissue Diagnostics Market Challenges
2.3.4 Cancer Tissue Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Tissue Diagnostics Players by Revenue
3.1.1 Global Top Cancer Tissue Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Cancer Tissue Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Tissue Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Tissue Diagnostics Revenue
3.4 Global Cancer Tissue Diagnostics Market Concentration Ratio
3.4.1 Global Cancer Tissue Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Tissue Diagnostics Revenue in 2021
3.5 Cancer Tissue Diagnostics Key Players Head office and Area Served
3.6 Key Players Cancer Tissue Diagnostics Product Solution and Service
3.7 Date of Enter into Cancer Tissue Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Tissue Diagnostics Breakdown Data by Type
4.1 Global Cancer Tissue Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2023-2028)
5 Cancer Tissue Diagnostics Breakdown Data by Application
5.1 Global Cancer Tissue Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Tissue Diagnostics Market Size (2017-2028)
6.2 North America Cancer Tissue Diagnostics Market Size by Country (2017-2022)
6.3 North America Cancer Tissue Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Cancer Tissue Diagnostics Market Size (2017-2028)
7.2 Europe Cancer Tissue Diagnostics Market Size by Country (2017-2022)
7.3 Europe Cancer Tissue Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Tissue Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Cancer Tissue Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Cancer Tissue Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Cancer Tissue Diagnostics Market Size (2017-2028)
9.2 Latin America Cancer Tissue Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Cancer Tissue Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Tissue Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd.
11.1.1 F. Hoffmann-La Roche Ltd. Company Detail
11.1.2 F. Hoffmann-La Roche Ltd. Business Overview
11.1.3 F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Ltd. Recent Development
11.2 Danaher Corporation
11.2.1 Danaher Corporation Company Detail
11.2.2 Danaher Corporation Business Overview
11.2.3 Danaher Corporation Cancer Tissue Diagnostics Introduction
11.2.4 Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.2.5 Danaher Corporation Recent Development
11.3 Thermo Fisher Scientific Inc.
11.3.1 Thermo Fisher Scientific Inc. Company Detail
11.3.2 Thermo Fisher Scientific Inc. Business Overview
11.3.3 Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Scientific Inc. Recent Development
11.4 Bio Rad Laboratories Inc.
11.4.1 Bio Rad Laboratories Inc. Company Detail
11.4.2 Bio Rad Laboratories Inc. Business Overview
11.4.3 Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Introduction
11.4.4 Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.4.5 Bio Rad Laboratories Inc. Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Cancer Tissue Diagnostics Introduction
11.5.4 Abbott Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.5.5 Abbott Recent Development
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Detail
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.6.5 Enzo Life Sciences, Inc. Recent Development
11.7 Agilent Technologies, Inc.
11.7.1 Agilent Technologies, Inc. Company Detail
11.7.2 Agilent Technologies, Inc. Business Overview
11.7.3 Agilent Technologies, Inc. Cancer Tissue Diagnostics Introduction
11.7.4 Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.7.5 Agilent Technologies, Inc. Recent Development
11.8 Cancer Genetics Inc.
11.8.1 Cancer Genetics Inc. Company Detail
11.8.2 Cancer Genetics Inc. Business Overview
11.8.3 Cancer Genetics Inc. Cancer Tissue Diagnostics Introduction
11.8.4 Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.8.5 Cancer Genetics Inc. Recent Development
11.9 Merck KGaA (Sigma-Aldrich Co. LLC)
11.9.1 Merck KGaA (Sigma-Aldrich Co. LLC) Company Detail
11.9.2 Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
11.9.3 Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Introduction
11.9.4 Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.9.5 Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
11.10 Abcam plc.
11.10.1 Abcam plc. Company Detail
11.10.2 Abcam plc. Business Overview
11.10.3 Abcam plc. Cancer Tissue Diagnostics Introduction
11.10.4 Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2017-2022)
11.10.5 Abcam plc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Cancer Tissue Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Immunohistochemistry (IHC) Test
Table 3. Key Players of In Situ Hybridisation Test
Table 4. Global Cancer Tissue Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Cancer Tissue Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Tissue Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cancer Tissue Diagnostics Market Share by Region (2017-2022)
Table 8. Global Cancer Tissue Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cancer Tissue Diagnostics Market Share by Region (2023-2028)
Table 10. Cancer Tissue Diagnostics Market Trends
Table 11. Cancer Tissue Diagnostics Market Drivers
Table 12. Cancer Tissue Diagnostics Market Challenges
Table 13. Cancer Tissue Diagnostics Market Restraints
Table 14. Global Cancer Tissue Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cancer Tissue Diagnostics Market Share by Players (2017-2022)
Table 16. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2021)
Table 17. Ranking of Global Top Cancer Tissue Diagnostics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cancer Tissue Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Tissue Diagnostics Product Solution and Service
Table 21. Date of Enter into Cancer Tissue Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Tissue Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2017-2022)
Table 25. Global Cancer Tissue Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cancer Tissue Diagnostics Revenue Market Share by Type (2023-2028)
Table 27. Global Cancer Tissue Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2017-2022)
Table 29. Global Cancer Tissue Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cancer Tissue Diagnostics Revenue Market Share by Application (2023-2028)
Table 31. North America Cancer Tissue Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Cancer Tissue Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Cancer Tissue Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Cancer Tissue Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Cancer Tissue Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Cancer Tissue Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Cancer Tissue Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Cancer Tissue Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 41. F. Hoffmann-La Roche Ltd. Company Detail
Table 42. F. Hoffmann-La Roche Ltd. Business Overview
Table 43. F. Hoffmann-La Roche Ltd. Cancer Tissue Diagnostics Product
Table 44. F. Hoffmann-La Roche Ltd. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 45. F. Hoffmann-La Roche Ltd. Recent Development
Table 46. Danaher Corporation Company Detail
Table 47. Danaher Corporation Business Overview
Table 48. Danaher Corporation Cancer Tissue Diagnostics Product
Table 49. Danaher Corporation Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 50. Danaher Corporation Recent Development
Table 51. Thermo Fisher Scientific Inc. Company Detail
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. Cancer Tissue Diagnostics Product
Table 54. Thermo Fisher Scientific Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 55. Thermo Fisher Scientific Inc. Recent Development
Table 56. Bio Rad Laboratories Inc. Company Detail
Table 57. Bio Rad Laboratories Inc. Business Overview
Table 58. Bio Rad Laboratories Inc. Cancer Tissue Diagnostics Product
Table 59. Bio Rad Laboratories Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 60. Bio Rad Laboratories Inc. Recent Development
Table 61. Abbott Company Detail
Table 62. Abbott Business Overview
Table 63. Abbott Cancer Tissue Diagnostics Product
Table 64. Abbott Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 65. Abbott Recent Development
Table 66. Enzo Life Sciences, Inc. Company Detail
Table 67. Enzo Life Sciences, Inc. Business Overview
Table 68. Enzo Life Sciences, Inc. Cancer Tissue Diagnostics Product
Table 69. Enzo Life Sciences, Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 70. Enzo Life Sciences, Inc. Recent Development
Table 71. Agilent Technologies, Inc. Company Detail
Table 72. Agilent Technologies, Inc. Business Overview
Table 73. Agilent Technologies, Inc. Cancer Tissue Diagnostics Product
Table 74. Agilent Technologies, Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 75. Agilent Technologies, Inc. Recent Development
Table 76. Cancer Genetics Inc. Company Detail
Table 77. Cancer Genetics Inc. Business Overview
Table 78. Cancer Genetics Inc. Cancer Tissue Diagnostics Product
Table 79. Cancer Genetics Inc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 80. Cancer Genetics Inc. Recent Development
Table 81. Merck KGaA (Sigma-Aldrich Co. LLC) Company Detail
Table 82. Merck KGaA (Sigma-Aldrich Co. LLC) Business Overview
Table 83. Merck KGaA (Sigma-Aldrich Co. LLC) Cancer Tissue Diagnostics Product
Table 84. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 85. Merck KGaA (Sigma-Aldrich Co. LLC) Recent Development
Table 86. Abcam plc. Company Detail
Table 87. Abcam plc. Business Overview
Table 88. Abcam plc. Cancer Tissue Diagnostics Product
Table 89. Abcam plc. Revenue in Cancer Tissue Diagnostics Business (2017-2022) & (US$ Million)
Table 90. Abcam plc. Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Tissue Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Immunohistochemistry (IHC) Test Features
Figure 3. In Situ Hybridisation Test Features
Figure 4. Global Cancer Tissue Diagnostics Market Share by Application in 2021 & 2028
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Cancer Tissue Diagnostics Report Years Considered
Figure 9. Global Cancer Tissue Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Cancer Tissue Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Cancer Tissue Diagnostics Market Share by Region: 2021 VS 2028
Figure 12. Global Cancer Tissue Diagnostics Market Share by Players in 2021
Figure 13. Global Top Cancer Tissue Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Tissue Diagnostics as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Cancer Tissue Diagnostics Revenue in 2021
Figure 15. North America Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 16. North America Cancer Tissue Diagnostics Market Share by Country (2017-2028)
Figure 17. United States Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Canada Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Cancer Tissue Diagnostics Market Share by Country (2017-2028)
Figure 21. Germany Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. France Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. U.K. Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Italy Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Russia Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Nordic Countries Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Cancer Tissue Diagnostics Market Share by Region (2017-2028)
Figure 29. China Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Japan Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. South Korea Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Southeast Asia Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. India Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Australia Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Cancer Tissue Diagnostics Market Share by Country (2017-2028)
Figure 37. Mexico Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Brazil Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Cancer Tissue Diagnostics Market Share by Country (2017-2028)
Figure 41. Turkey Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Saudi Arabia Cancer Tissue Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 44. Danaher Corporation Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 45. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 46. Bio Rad Laboratories Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 47. Abbott Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 48. Enzo Life Sciences, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 49. Agilent Technologies, Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 50. Cancer Genetics Inc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 51. Merck KGaA (Sigma-Aldrich Co. LLC) Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 52. Abcam plc. Revenue Growth Rate in Cancer Tissue Diagnostics Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche Ltd. Danaher Corporation Thermo Fisher Scientific Inc. Bio Rad Laboratories Inc. Abbott Enzo Life Sciences, Inc. Agilent Technologies, Inc. Cancer Genetics Inc. Merck KGaA (Sigma-Aldrich Co. LLC) Abcam plc.